Ocean Biomedical, Inc.
OCEA
$0.04
-$0.0015-3.61%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | -60.32% | -87.41% | -70.09% | -52.94% | 23.25% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -62.82% | -88.27% | -73.46% | -66.93% | -36.64% |
| Operating Income | 62.82% | 88.27% | 73.46% | 66.93% | 36.64% |
| Income Before Tax | 91.72% | 73.00% | 60.10% | 65.06% | -559.40% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 91.72% | 73.00% | 60.10% | 65.06% | -559.40% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 91.72% | 73.00% | 60.10% | 65.06% | -559.40% |
| EBIT | 62.82% | 88.27% | 73.46% | 66.93% | 36.64% |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | 92.36% | 75.13% | 63.23% | 67.67% | -503.36% |
| Normalized Basic EPS | 91.17% | 70.58% | 56.05% | 62.79% | -422.09% |
| EPS Diluted | 92.36% | 75.13% | 63.23% | 67.67% | -503.36% |
| Normalized Diluted EPS | 91.17% | 70.58% | 56.05% | 62.79% | -422.09% |
| Average Basic Shares Outstanding | 4.63% | 8.19% | 10.88% | 13.45% | 12.53% |
| Average Diluted Shares Outstanding | 4.63% | 8.19% | 10.88% | 13.45% | 12.53% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |